Story thread · 12 reports / 11 sources
Tirzepatide Beats Semaglutide for Weight Loss, Not Safety
medscape.com · 5d
How the coverage leans
Across 11 sources · syndicated copies counted once
Tirzepatide may provide greater weight loss than semaglutide in adults with overweight or obesity, but this advantage comes at the cost of a higher risk for serious adverse events. Medscape Medical News
First report: More children under 12 in U.S. are being prescribed weight-loss drugs, study finds — thehindu.com, 8d
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.